Search Results - "McCluskey, Leo"
-
1
Stages of pTDP-43 pathology in amyotrophic lateral sclerosis
Published in Annals of neurology (01-07-2013)“…Objective To see whether the distribution patterns of phosphorylated 43kDa TAR DNA‐binding protein (pTDP‐43) intraneuronal inclusions in amyotrophic lateral…”
Get full text
Journal Article -
2
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Published in Science (American Association for the Advancement of Science) (06-10-2006)“…Ubiquitin-positive, tau- and α-synuclein-negative inclusions are hallmarks of frontotemporal lobar degeneration with ubiquitin-positive inclusions and…”
Get full text
Journal Article -
3
Circulating brain-enriched microRNAs as novel biomarkers for detection and differentiation of neurodegenerative diseases
Published in Alzheimer's research & therapy (09-11-2017)“…Minimally invasive specific biomarkers of neurodegenerative diseases (NDs) would facilitate patient selection and disease progression monitoring. We describe…”
Get full text
Journal Article -
4
Poly(GP) proteins are a useful pharmacodynamic marker for C9ORF72 -associated amyotrophic lateral sclerosis
Published in Science translational medicine (29-03-2017)“…There is no effective treatment for amyotrophic lateral sclerosis (ALS), a devastating motor neuron disease. However, discovery of a G C repeat expansion in…”
Get more information
Journal Article -
5
Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology
Published in Acta neuropathologica (01-09-2018)“…Neurogranin (Ng) is a post-synaptic protein that previously has been shown to be a biomarker for synaptic function when measured in cerebrospinal fluid (CSF)…”
Get full text
Journal Article -
6
Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study
Published in Lancet neurology (01-04-2012)“…Summary Background We aimed to accurately estimate the frequency of a hexanucleotide repeat expansion in C9orf72 that has been associated with a large…”
Get full text
Journal Article -
7
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial
Published in Lancet neurology (01-12-2007)“…Summary Background Minocycline has anti-apoptotic and anti-inflammatory effects in vitro, and extends survival in mouse models of some neurological conditions…”
Get full text
Journal Article -
8
TDP-43 pathology and neuronal loss in amyotrophic lateral sclerosis spinal cord
Published in Acta neuropathologica (01-09-2014)“…We examined the phosphorylated 43-kDa TAR DNA-binding protein (pTDP-43) inclusions as well as neuronal loss in full-length spinal cords and five selected…”
Get full text
Journal Article -
9
Defining SOD1 ALS natural history to guide therapeutic clinical trial design
Published in Journal of neurology, neurosurgery and psychiatry (01-02-2017)“…ImportanceUnderstanding the natural history of familial amyotrophic lateral sclerosis (ALS) caused by SOD1 mutations (ALSSOD1) will provide key information for…”
Get full text
Journal Article -
10
Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis
Published in PloS one (14-06-2012)“…We evaluated clinicopathological correlates of upper motor neuron (UMN) damage in amyotrophic lateral sclerosis (ALS), and analyzed if the presence of the…”
Get full text
Journal Article -
11
Characterization of Parkinson's disease using blood-based biomarkers: A multicohort proteomic analysis
Published in PLoS medicine (11-10-2019)“…Parkinson's disease (PD) is a progressive neurodegenerative disease affecting about 5 million people worldwide with no disease-modifying therapies. We sought…”
Get full text
Journal Article -
12
Hypermethylation of repeat expanded C9orf72 is a clinical and molecular disease modifier
Published in Acta neuropathologica (01-01-2015)“…C9orf72 promoter hypermethylation inhibits the accumulation of pathologies which have been postulated to be neurotoxic. We tested here whether C9orf72…”
Get full text
Journal Article -
13
Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis
Published in Journal of neurology, neurosurgery and psychiatry (01-02-2013)“…Background Significant heterogeneity in clinical features of frontotemporal lobar degeneration (FTLD) and amyotrophic lateral sclerosis (ALS) cases with the…”
Get full text
Journal Article -
14
Plasma multianalyte profiling in mild cognitive impairment and Alzheimer disease
Published in Neurology (28-08-2012)“…While plasma biomarkers have been proposed to aid in the clinical diagnosis of Alzheimer disease (AD), few biomarkers have been validated in independent…”
Get full text
Journal Article -
15
Evaluating the role of the FUS/TLS-related gene EWSR1 in amyotrophic lateral sclerosis
Published in Human molecular genetics (01-07-2012)“…Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting motor neurons. Mutations in related RNA-binding proteins TDP-43, FUS/TLS and…”
Get full text
Journal Article -
16
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis
Published in Lancet neurology (01-05-2008)“…Summary Background TDP-43 is a major component of the ubiquitinated inclusions that characterise amyotrophic lateral sclerosis (ALS) and frontotemporal lobar…”
Get full text
Journal Article -
17
Phosphorylated tau as a candidate biomarker for amyotrophic lateral sclerosis
Published in JAMA neurology (01-04-2014)“…An increasingly varied clinical spectrum of cases with amyotrophic lateral sclerosis (ALS) has been identified, and objective criteria for clinical trial…”
Get more information
Journal Article -
18
Pattern of ubiquilin pathology in ALS and FTLD indicates presence of C9ORF72 hexanucleotide expansion
Published in Acta neuropathologica (01-06-2012)“…C9ORF72 -hexanucleotide repeat expansions and ubiquilin-2 ( UBQLN2 ) mutations are recently identified genetic markers in amyotrophic lateral sclerosis (ALS)…”
Get full text
Journal Article -
19
UNC13A polymorphism contributes to frontotemporal disease in sporadic amyotrophic lateral sclerosis
Published in Neurobiology of aging (01-01-2019)“…The majority (90%–95%) of amyotrophic lateral sclerosis (ALS) is sporadic, and ∼50% of patients develop symptoms of frontotemporal degeneration (FTD)…”
Get full text
Journal Article -
20
Enrichment of C-Terminal Fragments in TAR DNA-Binding Protein-43 Cytoplasmic Inclusions in Brain but not in Spinal Cord of Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Published in The American journal of pathology (01-07-2008)“…TAR DNA-binding protein (TDP-43) has been recently described as a major pathological protein in both frontotemporal dementia with ubiquitin-positive inclusions…”
Get full text
Journal Article